Jane Street Group, LLC Evelo Biosciences, Inc. Transaction History

Jane Street Group, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$6.07 - $12.0 $68,384 - $135,192	-11,266 Closed	0 $0
Q3 2021 Nov 16, 2021	BUY	$6.79 - $13.9 $76,496 - $156,597	11,266 New	11,266 $79,000
Q2 2021 Aug 16, 2021	SELL	$9.43 - $16.6 $117,752 - $207,284	-12,487 Closed	0 $0
Q1 2021 May 18, 2021	SELL	$9.71 - $18.6 $46,928 - $89,893	-4,833 Reduced 27.9%	12,487 $134,000
Q4 2020 Feb 17, 2021	BUY	$3.91 - $12.28 $67,721 - $212,689	17,320 New	17,320 $209,000

Q2 2019 Aug 15, 2019	SELL	$6.52 - $9.42 $118,774 - $171,604	-18,217 Closed	0 $0
Q1 2019 May 16, 2019	SELL	$7.5 - $15.31 $11,760 - $24,006	-1,568 Reduced 7.93%	18,217 $146,000
Q4 2018 Feb 15, 2019	BUY	$7.29 - $13.01 $15,848 - $28,283	2,174 Added 12.34%	19,785 $257,000
Q3 2018 Nov 14, 2018	SELL	$11.93 - $14.76 $109,779 - $135,821	-9,202 Reduced 34.32%	17,611 $215,000
Q2 2018 Aug 15, 2018	BUY	$11.39 - $16.26 $305,400 - $435,979	26,813 New	26,813 $316,000

Ticker EVLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,994,000
Description
Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in Phase 2 clinical trial for the treatment of psoriasis and atopic dermatitis, as well as for the hy...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.